RxDoctor Payments Data

David Johnson, MD

Family Medicine · Jacksonville Beach, FLNPI 1386616795

Payments from drug & device makers

$8,978in general payments, 2019–2025

Across 517 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$971
  • Amgen$770
  • Abbott$683
  • Lilly USA, LLC$579
  • Novo Nordisk$383
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$8,963100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)79$1,064
Pfizer70$971
Amgen(2 entities)53$770
Abbott16$683
Lilly USA, LLC36$579
Novo Nordisk24$383
AstraZeneca21$376
Merck17$280
Astellas Pharma US Inc14$275
GSK14$255
Boehringer Ingelheim14$245
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$196
Sumitomo Pharma America, Inc.9$183
Supernus Pharmaceuticals, Inc.13$175
Teva Pharmaceuticals USA, Inc.10$171
Otsuka America Pharmaceutical, Inc.7$158
Biohaven Pharmaceuticals, Inc.7$153
SPR Therapeutics, Inc1$153
Antares Pharma, Inc.7$150
Phathom Pharmaceuticals, Inc.6$132
Vanda Pharmaceuticals Inc.6$91
Bard Peripheral Vascular, Inc.1$84
Novartis4$83
Exact Sciences5$79
Jazz Pharmaceuticals Inc.5$78
Kowa Pharmaceuticals America, Inc.4$76
Axsome Therapeutics, Inc.3$75
Daiichi Sankyo Inc.4$65
Sunovion Pharmaceuticals Inc.3$58
Biohaven Pharmaceutical Holding Company Ltd.3$56
Cerapedics Inc.1$53
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$50
Medtronic3$49
Dexcom, Inc.3$48
Bayer2$48
Corcept Therapeutics2$44
Amarin Pharma, Inc.2$40
Johnson & Johnson2$34
Mycovia Pharmaceuticals, Inc.2$33
Hikma Pharmaceuticals USA2$31
Arbor Pharmaceuticals, Inc.2$30
Noven Therapeutics, LLC2$30
Endo Pharmaceuticals Inc.2$30
IBSA Pharma Inc.2$29
E.r. Squibb & Sons, L.L.C.1$25
Genentech USA, Inc.1$25
Aytu Biopharma, Inc.1$23
Heron Therapeutics, Inc.1$21
Halozyme Inc1$20
Abiomed1$20
Sanofi Pasteur Inc.1$20
Esperion Therapeutics, Inc.1$19
Phadia US Inc.1$19
Shire North American Group Inc1$18
Almatica Pharma LLC1$17
Cranial Technologies, Inc1$17
Curonix LLC1$16
Gilead1$16
Irhythm Technologies, Inc.1$15
Eisai Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,978 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$132,898
Medicare patients
370
Services billed
1,511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gamunex-CImmune Globul G/Gly/Iga Avg 4617$330,955
JardianceEmpagliflozin71$66,741
EliquisApixaban61$42,283
MounjaroTirzepatide38$40,909
OzempicSemaglutide40$38,977
RybelsusSemaglutide33$33,807
JanuviaSitagliptin Phosphate20$32,987
TrulicityDulaglutide23$32,536
Xtampza ErOxycodone Myristate23$26,697
FarxigaDapagliflozin Propanediol22$26,126
XareltoRivaroxaban24$24,715
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$18,743
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen158$8,291
OxycontinOxycodone Hcl12$7,350
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen222$7,078

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$579$73,44661 claims
Novo NordiskOzempic, Rybelsus$383$72,78373 claims
Boehringer IngelheimJardiance$245$66,74171 claims
PfizerEliquis$971$42,28361 claims
MerckJanuvia$280$32,98720 claims
AstraZenecaFarxiga, Brilinta$376$31,20533 claims
Johnson & JohnsonXarelto$34$24,71524 claims
GSKTrelegy Ellipta, Breo Ellipta$255$23,35632 claims
AbbVieSynthroid$1,064$2,58337 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →